Susan A. Jansen‐Varnum

Author

Temple University

Also Known As

S A Jansen-Varnum, Susan A Jansen-Varnum, Susan A. Jansen-Varnum, Susan A. Jansen‐Varnum, Susan Jansen-Varnum

Publications

371

Citations

H-Index

Concepts

All Affiliations

Temple University Fredric Rieders Family Foundation Tripler Army Medical Center Banner Life Sciences (United States)

About

Susan A. Jansen‐Varnum is an author at Temple University specializing in engineering, drug discovery, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	3	3	196
2	Medicine	2	2	28
3	Natural Sciences	1	1	12
4	Biochemistry	1	1	12
5	Biomedical Engineering	1	1	16

Susan A. Jansen‐Varnum

Publications

306

Citations

H-Index

Page 1

	Year	Citations
Preparation and Physisorption Characterization of <scp>d</scp>-Glucose-Templated Mesoporous Silica Sol−Gel Materials Yen Wei, Jigeng Xu, Hua Dong, Chemistry of Materials Chemical EngineeringBiomanufacturingEngineeringPhysisorption CharacterizationNanoporous Material	1999	157
The synthesis and characterization of Ni, Pd and Pt maleonitriledithiolate complexes: X-ray crystal structures of the isomorphous Ni, Pd and Pt (Ph2PCH2CH2PPh2)M(maleonitriledithiolate) congeners Katy G. Landis, A.D. Hunter, Timothy R. Wagner, Inorganica Chimica Acta Inorganic ChemistryEngineeringCoordination ComplexMolecular ComplexPt Maleonitriledithiolate Complexes	1998	23
Metabolic profiling of synthetic cannabinoid 5F‐ADB and identification of metabolites in authentic human blood samples via human liver microsome incubation and ultra‐high‐performance liquid chromatography/high‐resolution mass spectrometry Brandon C. Presley, Marisol S. Castaneto, Barry K. Logan, Rapid Communications in Mass Spectrometry	2020	19
In Vitro–In Vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development Zachary N. Warnken, Michael M. Puppolo, Justin R. Hughey, Journal of Pharmaceutical Sciences NanomedicinePharmaceutical ScienceEngineeringCarbamazepine NanodispersionsTherapeutic Nanomaterials	2017	16
<i>In vitro</i> Phase I metabolism of indazole carboxamide synthetic cannabinoid MDMB‐CHMINACA via human liver microsome incubation and high‐resolution mass spectrometry Brandon C. Presley, Barry K. Logan, Susan A. Jansen‐Varnum Drug Testing and Analysis	2019	16
<i>In vitro</i> evaluation of orthopedic composite cytotoxicity: Assessing the potential for postsurgical production of hydroxyl radicals Michael DiCicco, Ryan Compton, Susan A. Jansen‐Varnum Journal of Biomedical Materials Research Part B Applied Biomaterials	2004	15
Plasma modification of microporous polymer membranes for application in biomimetic dissolution studies Michael M. Puppolo, Justin R. Hughey, Bruce A. Weber, AAPS Open	2017	15
Biomimetic Dissolution: A Tool to Predict Amorphous Solid Dispersion Performance Michael M. Puppolo, Justin R. Hughey, Traciann Dillon, AAPS PharmSciTech Materials ScienceLiquid-liquid FlowDispersionAmorphous SolidBiomimetic Dissolution	2017	12
In Vitro Metabolic Profile Elucidation of Synthetic Cannabinoid APP-CHMINACA (PX-3) Brandon C. Presley, Barry K. Logan, Susan A. Jansen‐Varnum Journal of Analytical Toxicology Amide HydrolysisMultiple Synthetic CannabinoidsPharmacotherapyMetabolic RemodelingMedicinal Chemistry	2019	12
Assessment of synthetic cannabinoid FUB‐AMB and its ester hydrolysis metabolite in human liver microsomes and human blood samples using UHPLC–MS/MS Brandon C. Presley, Marisol S. Castaneto, Barry K. Logan, Biomedical Chromatography	2020	11

Page 1